These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15663911)

  • 1. Atherosclerosis and restenosis: is there a role for RAGE?
    Nawroth P; Bierhaus A; Marrero M; Yamamoto H; Stern DM
    Curr Diab Rep; 2005 Feb; 5(1):11-6. PubMed ID: 15663911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.
    Basta G
    Atherosclerosis; 2008 Jan; 196(1):9-21. PubMed ID: 17826783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
    Schmidt AM; Yan SD; Wautier JL; Stern D
    Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease.
    Bucciarelli LG; Wendt T; Rong L; Lalla E; Hofmann MA; Goova MT; Taguchi A; Yan SF; Yan SD; Stern DM; Schmidt AM
    Cell Mol Life Sci; 2002 Jul; 59(7):1117-28. PubMed ID: 12222959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE: a novel target for drug intervention in diabetic vascular disease.
    Hudson BI; Schmidt AM
    Pharm Res; 2004 Jul; 21(7):1079-86. PubMed ID: 15290845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
    Stern DM; Yan SD; Yan SF; Schmidt AM
    Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis and diabetes: the RAGE connection.
    Schmidt AM; Stern D
    Curr Atheroscler Rep; 2000 Sep; 2(5):430-6. PubMed ID: 11122775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: insights into the pathogenesis of macrovascular complications in diabetes.
    Wendt T; Bucciarelli L; Qu W; Lu Y; Yan SF; Stern DM; Schmidt AM
    Curr Atheroscler Rep; 2002 May; 4(3):228-37. PubMed ID: 11931721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
    Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of RAGE for attenuating progression of diabetic vascular complications.
    Win MT; Yamamoto Y; Munesue S; Saito H; Han D; Motoyoshi S; Kamal T; Ohara T; Watanabe T; Yamamoto H
    Exp Diabetes Res; 2012; 2012():894605. PubMed ID: 22110482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure.
    Aronson D
    Med Hypotheses; 2002 Sep; 59(3):297-301. PubMed ID: 12208156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
    Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
    Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RAGE axis: Animal models and novel insights into the vascular complications of diabetes.
    Naka Y; Bucciarelli LG; Wendt T; Lee LK; Rong LL; Ramasamy R; Yan SF; Schmidt AM
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1342-9. PubMed ID: 15155381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAGE biology, atherosclerosis and diabetes.
    Barlovic DP; Soro-Paavonen A; Jandeleit-Dahm KA
    Clin Sci (Lond); 2011 Jul; 121(2):43-55. PubMed ID: 21457145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease.
    Schmidt AM; Stern DM
    Front Biosci; 2001 Oct; 6():D1151-60. PubMed ID: 11578972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unlocking the biology of RAGE in diabetic microvascular complications.
    Manigrasso MB; Juranek J; Ramasamy R; Schmidt AM
    Trends Endocrinol Metab; 2014 Jan; 25(1):15-22. PubMed ID: 24011512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.
    Ramasamy R; Yan SF; Schmidt AM
    Trends Cardiovasc Med; 2005 Oct; 15(7):237-43. PubMed ID: 16226677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings.
    Stern D; Yan SD; Yan SF; Schmidt AM
    Adv Drug Deliv Rev; 2002 Dec; 54(12):1615-25. PubMed ID: 12453678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of advanced glycation endproducts (AGE) and receptor for AGE on vascular smooth muscle cell growth.
    Wang R; Kudo M; Yokoyama M; Asano G
    J Nippon Med Sch; 2001 Dec; 68(6):472-81. PubMed ID: 11744927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biology of the receptor for advanced glycation end products and its ligands.
    Schmidt AM; Yan SD; Yan SF; Stern DM
    Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.